Frank Morich - Net Worth and Insider Trading
Frank Morich Net Worth
The estimated net worth of Frank Morich is at least $48,160 dollars as of 2024-11-10. Frank Morich is the Director of Cue Biopharma Inc and owns about 28,000 shares of Cue Biopharma Inc (CUE) stock worth over $48,160. Details can be seen in Frank Morich's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Frank Morich has not made any transactions after 2022-05-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Frank Morich
Frank Morich Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Frank Morich owns 2 companies in total, including Cue Biopharma Inc (CUE) , and Perspective Therapeutics Inc (CATX) .
Click here to see the complete history of Frank Morich’s form 4 insider trades.
Insider Ownership Summary of Frank Morich
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CUE | Cue Biopharma Inc | 2022-05-27 | director |
| CATX | Perspective Therapeutics Inc | 2023-02-03 | director |
Frank Morich Latest Holdings Summary
Frank Morich currently owns a total of 1 stock. Frank Morich owns 28,000 shares of Cue Biopharma Inc (CUE) as of May 27, 2022, with a value of $48,160.
Latest Holdings of Frank Morich
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CUE | Cue Biopharma Inc | 2022-05-27 | 28,000 | 1.72 | 48,160 |
Holding Weightings of Frank Morich
Frank Morich Form 4 Trading Tracker
According to the SEC Form 4 filings, Frank Morich has made a total of 1 transactions in Cue Biopharma Inc (CUE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cue Biopharma Inc is the acquisition of 28,000 shares on May 27, 2022, which cost Frank Morich around $105,000.
Insider Trading History of Frank Morich
- 1
Frank Morich Trading Performance
GuruFocus tracks the stock performance after each of Frank Morich's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Frank Morich is -27.2%. GuruFocus also compares Frank Morich's trading performance to market benchmark return within the same time period. The performance of stocks bought by Frank Morich within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Frank Morich's insider trading performs compared to the benchmark.
Performance of Frank Morich
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -26.17 | | | | | |
| Relative Return to S&P 500(%) | -19.96 | | | | | |
Frank Morich Ownership Network
Ownership Network List of Frank Morich
Ownership Network Relation of Frank Morich
Frank Morich Owned Company Details
What does Cue Biopharma Inc do?
Who are the key executives at Cue Biopharma Inc?
Frank Morich is the director of Cue Biopharma Inc. Other key executives at Cue Biopharma Inc include President and CSO Anish Suri , director & CEO Daniel R Passeri , and Chief Medical Officer Matteo Levisetti .
Cue Biopharma Inc (CUE) Insider Trades Summary
Over the past 18 months, Frank Morich made no insider transaction in Cue Biopharma Inc (CUE). Other recent insider transactions involving Cue Biopharma Inc (CUE) include a net purchase of 4,000 shares made by Anish Suri , and a net purchase of 3,000 shares made by Daniel R Passeri .
In summary, during the past 3 months, insiders sold 0 shares of Cue Biopharma Inc (CUE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cue Biopharma Inc (CUE) were sold and 7,000 shares were bought by its insiders, resulting in a net purchase of 7,000 shares.
Cue Biopharma Inc (CUE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cue Biopharma Inc Insider Transactions
Frank Morich Mailing Address
Above is the net worth, insider trading, and ownership report for Frank Morich. You might contact Frank Morich via mailing address: 40 Guest Street, Boston Ma 02135.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
